Reverse Transcriptase Inhibitors: all 1,328 studies that test it
Page 6 of 14. Open to participants first (42), then studies with results posted, then the rest; newest registration first within each.
- The Stay Study: A Demonstration Project Advancing PrEP Delivery in the San Francisco Bay Area Transgender CommunityCompletedNCT03120936Phase 4
- Evaluating the Feasibility and Acceptability of Implementing a PrEP Program in PR-CoNCRA (San Juan, Puerto Rico)- Part BStatus unknownNCT03120494Phase 4
- Prevention of HIV in "Île-de-France"Status unknownNCT03113123Not applicable
- Changes in Insulin Sensitivity in Healthy Volunteers Taking Tenofovir Alafenamide (TAF)-Containing Antiretroviral MedicationCompletedNCT03092206Phase 1
- Study of HIV-Infected and Uninfected Pregnant Woman/Child Dyads in Gaborone, BotswanaCompletedNCT03088410Phase 4
- Reversing the Epidemic in Africa With Choices in HIV Prevention (REACH)WithdrawnNCT03074786Phase 2
- Finding the Right Tenofovir/Emtricitabine Regimen for Pre-Exposure Prophylaxis (PrEP) in Transgender WomenCompletedNCT03060785Phase 1
- The Partners Scale-Up ProjectCompletedNCT03052010Phase 4
- Rilpivirine in Virologically Suppressed AdolescentsStatus unknownNCT03033368Phase 2/3
- Study of the Relative Oral Bioavailability of AL-3778 Tablets and Drug Interaction With Entecavir or Tenofovir Disoproxil Fumarate in Healthy VolunteersTerminatedNCT03032536Phase 1
- Tenofovir Adherence to Rapidly Guide and Evaluate PrEP and HIV TherapyCompletedNCT03012607Not applicable
- CMV-CTL for the Treatment of CMV Infection After HSCTCompletedNCT03004261Phase 4
- Tenofovir in Early Pregnancy to Prevent Mother-to-child Transmission of Hepatitis B VirusCompletedNCT02995005Phase 1/2
- Study to Evaluate the Relative Bioavailability of Fixed-dose Combination Tablet Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) as a Whole Tablet, as a Split Tablet, and as Crushed Tablet in Healthy Adult ParticipantsCompletedNCT02984852Phase 1
- Dosing of Tenofovir and Efavirenz in Antiretroviral TherapyCompletedNCT02945163Phase 4
- Tenofovir As Prevention Of Hepatitis b Mother-to-child TransmissionStatus unknownNCT02937779Phase 4
- Optimization of Antiretroviral TherapyCompletedNCT02935075Phase 4
- A Randomized, Open-label, Single-dosing, 2X2 Crossover Study to Compare the Safety and Pharmacokinetics of BR-TND Tablet(Tenofovir Disoproxil) With Viread Tablet(Tenofovir Disoproxil Fumarate) in Healthy Male VolunteersCompletedNCT02920931Phase 1
- Expanded PrEP Implementation in Communities in NSWCompletedNCT02870790Phase 3
- Pharmacokinetics of Efavirenz in the Presence of Rifampicin and IsoniazidStatus unknownNCT02832778Phase 1
- Clinical Trial to Evaluate Drug-drug Interactions Between Darunavir/Cobicistat and Etravirine in Hiv- Infected PatientsCompletedNCT02818348Phase 1
- Tenofovir Alafenamide Fumarate (TAF) Effect on Residual Intrathecal Immune ActivationCompletedNCT02771054Phase 4
- Darunavir/Ritonavir + Lamivudine Versus Darunavir/Ritonavir +Emtricitabine/Tenofovir in Naïve HIV-1 Infected SubjectsCompletedNCT02770508Phase 4
- Introducing PrEP Into HIV Combination Prevention - KenyaStatus unknownNCT02755350Not applicable
- A Study Evaluating the Safety, Pharmacokinetics, and Antiviral Efficacy of SB 9200 in Subjects Infected With Chronic HBVCompletedNCT02751996Phase 2
- Drug Transporter Interaction Study PHENTRA_2015_KPUKCompletedNCT02743260Phase 4
- Relative Bio-availability Study of Dolutegravir and Lamivudine Fixed Dose CombinationsCompletedNCT02738931Phase 1
- Pharmacologic Strategies to Use the Levonorgestrel Implant in HIV-infected WomenCompletedNCT02722421Phase 2
- Antiretroviral Regime for Viral Eradication in NewbornsCompletedNCT02712801Phase 4
- Dose Optimisation of Stavudine for the Treatment of HIV InfectionCompletedNCT02670772Phase 3
- Triumeq As an Integrase Single Tablet Regimen in People With HIV Who Inject DrugsTerminatedNCT02659761Phase 4
- Immediate Initiation of Antiretroviral Therapy During "Hyperacute" HIV InfectionActive, not recruitingNCT02656511Phase 4
- ART Drug Dosage Adjustment in HIV-infected PopulationCompletedNCT02632474Phase 4
- Bioequivalence Study Between Lamivudine Formulations in the Form of Coated Tablet of 150 mg in Healthy VolunteersCompletedNCT02604004Phase 1
- Use of TDF in Patients With Inactive Chronic Hepatitis B InfectionCompletedNCT02600117Phase 3
- HIV PrEP Priming of Immune EffectorsStatus unknownNCT02593409Phase 4
- To Compare the Efficacy of a Prophylactic Use of Tenofovir by Duration for the Non-Hodgkin's LymphomaStatus unknownNCT02585947Phase 4
- Bioequivalence Study of Two Formulations With the Association of Tenofovir 300 mg and Emtricitabine 200 mg.CompletedNCT02583464Phase 1
- A Bioequivalence Study of Darunavir, Emtricitabine, and Tenofovir Alafenamide, in the Presence of Cobicistat in Healthy ParticipantsCompletedNCT02578550Phase 1
- Pre-Exposure Prophylaxis and Timed Intercourse for HIV-Discordant CouplesWithdrawnNCT02572505Not applicable
- Pharmacokinetics of Atazanavir /Dolutegravir/Lamivudine Regimen as Maintenance RegimenTerminatedNCT02566707Phase 2
- Relative Bioavailability of Three Oral Formulations Candidates of Rilpivirine for Potential Pediatric Use Compared to Oral TabletCompletedNCT02561936Phase 1
- An Exploratory Study of RGT Strategy on Optimal NUC-experienced PatientsStatus unknownNCT02560649Phase 4
- Clinical Trial to Assess the Safety and Pharmacokinetics of DA-2802 319mg and Viread 300mg in Healthy Male VolunteersCompletedNCT02557594Phase 1
- DAAs Treatment for Chronic HCV/HBV Co-infection Patients(DASCO)CompletedNCT02555943Phase 2/3
- Evolution of Plasma Lipid Profile in Patients With HIV1 Who Change Atripla to Eviplera Compared to Continue With AtriplaCompletedNCT02547844Phase 4
- A Study to Evaluate the Pharmacokinetics of Rilpivirine/Tenofovir/Emtricitabine After a Single-Oral Administration in Healthy Japanese Adult Male ParticipantsCompletedNCT02530060Phase 4
- SSAT058: Atripla to Eviplera Switch in Patients Without Central Nervous System SymptomsCompletedNCT02529059Phase 4
- A Trial Evaluating Maintenance Therapy With Lamivudine (Epivir®) and Dolutegravir (Tivicay®) in Human Immunodeficiency Virus 1 (HIV-1) Infected Patients Virologically Suppressed With Triple Highly Active Antiretroviral Therapy (HAART) (ANRS 167 Lamidol)CompletedNCT02527096Phase 2
- Optimal Time for Tenofovir Treatment of Anti-Hepatitis B Virus (HBV) During the PregnancyStatus unknownNCT02510963Not applicable
- Efficacy of HBV Vaccine in Consolidation of Nucleos(t)Ide Analogues TherapyCompletedNCT02505009Phase 4
- SSAT063- Pharmacokinetics of Efavirenz 400 mg Once Daily During Pregnancy in HIV-1 Infected WomenCompletedNCT02499874Phase 1
- A Roll-over Study With Rilpivirine for Human Immunodeficiency Virus Type 1 (HIV-1) Infected Participants Who Participated in Rilpivirine Pediatric StudiesActive, not recruitingNCT02494986Phase 2
- Relative Bioavailability and Food Effect for Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Fixed Dose CombinationCompletedNCT02475135Phase 1
- Demonstration Project of PrEP Among Female Sex Workers in Dakar, SenegalCompletedNCT02474303Not applicable
- Cost-effectiveness of Different Antiretroviral Treatment in Patients HIV NaiveWithdrawnNCT02470650Phase 4
- Roll-over After 3-year Trial for Tenofovir in Mild Chronic Hepatitis BStatus unknownNCT02463019Phase 4
- 'Tenofovir Pulse and Peg Interferon Alpha 2b' Therapy in HBeAg-positive Patients With Normal ALTWithdrawnNCT02454764Not applicable
- Comprehensive HIV Prevention Package for MSM in Port ElizabethCompletedNCT02449733Not applicable
- Decrease of Neuropsychiatric Side Effects After Switching From Atripla to EvipleraTerminatedNCT02447016Phase 4
- Latency and Early Neonatal Provision of Antiretroviral Drugs Clinical TrialCompletedNCT02431975Phase 4
- Influence of Cytochrome P2B6 on Efavirenz Dose in HIV-infected Thai PatientsStatus unknownNCT02421289Phase 1
- Open Label, Pilot Study of Darunavir Boosted by Cobicistat in Combination With Rilpivirine to Treat HIV+ Naïve SubjectsStatus unknownNCT02404233Phase 4
- Early Infant HIV Treatment in BotswanaActive, not recruitingNCT02369406Phase 2/3
- Reverse Transcriptase Inhibitors in AGSCompletedNCT02363452Phase 2
- Safety, Tolerability and Pharmacokinetic Study of MB12066 in Healthy Male VolunteersCompletedNCT02338856Phase 1
- TDF and LdT in Immune-tolerant CHB Patients Awaiting Assisted ReproductionCompletedNCT02338674Phase 1/2
- Lamivudine Extending Therapy in Chronic Hepatitis B Patients After 3-year of Oral Antiviral AgentsStatus unknownNCT02337127Phase 4
- Emtricitabine for Prevention of Vertical Transmission of HBV in Chinese Pregnant HBsAg Positive PatientsStatus unknownNCT02327715Phase 4
- Emtricitabine for Naive Chinese Pregnant Chronic Hepatitis B PatientsStatus unknownNCT02327702Phase 4
- Emtricitabine Plus Adefovir Dipivoxil for Naive Chinese HBV Related Cirrhosis PatientsStatus unknownNCT02327689Phase 4
- Emtricitabine for Naive Child Chinese Chronic Hepatitis B PatientsStatus unknownNCT02327676Phase 4
- Emtricitabine for Naive Chinese Chronic Hepatitis B PatientsStatus unknownNCT02327663Phase 4
- Effect of SwitChing AtriPla to Eviplera on Neurocognitive and Emotional FunctioningCompletedNCT02308332Phase 4
- Prompt Or Watchful Monitoring for Hepatitis B Virus Related Hepatocellular Carcinoma Without Elevated viRal LoadStatus unknownNCT02308319Phase 4
- Trial to Evaluate the Interest of a Reductive Anti Retroviral Strategy Using Dual Therapy Inspite of Triple TherapyCompletedNCT02302547Phase 3
- Efavirenz to Dolutegravir Switch in Patients With CNS ToxicityStatus unknownNCT02285374Phase 4
- Comparison of Tenofovir Vaginal Gel and Film FormulationsCompletedNCT02280109Early Phase 1
- Raltegravir Versus Efavirenz in Naive HIV-1-infected Patients Receiving Rifampin for Active TuberculosisCompletedNCT02273765Phase 3
- Study of Pharmacokinetic Interaction Between Combivir® (ZDV+3TC) and BILR 355 BS Plus Ritonavir in Healthy SubjectsCompletedNCT02256774Phase 1
- Pharmacokinetic Interaction Between TRUVADA™ and BILR 355 BS Plus Ritonavir in Healthy VolunteersCompletedNCT02253901Phase 1
- Tipranavir Dose-response Study Using a Prototype Self-emulsifying Drug Delivery System (SEDDS) Formulation in Treatment-naive HIV-1 Infected Patients Report on the Post-study Option, a Treatment of Triple Therapy With Delavirdine, ZDV and 3TC Without TipranavirCompletedNCT02249130Phase 2
- A Trial Comparing Entacavir and Tenofovir in Patients With HBV Decompensated CirrhosisStatus unknownNCT02238860Phase 4
- Effects of Steady-state Efavirenz 600 mg QD (Sustiva®) on Tipranavir Concentration at Steady-state in Healthy Adult VolunteersCompletedNCT02226991Phase 1
- Dolutegravir-Lamivudine as Dual Therapy in Naive HIV-Infected Patients: A Pilot StudyCompletedNCT02211482Phase 4
- PrEP Demonstration Project (PRELUDE Study)CompletedNCT02206555Phase 4
- Oxymatrine Plus Lamivudine Combination Therapy Versus Lamivudine Monotherapy for Chronic Hepatitis B Infected SubjectsCompletedNCT02202473Phase 4
- Multiple Dose BE Study With Nevirapine 400mg PR TabletsCompletedNCT02202005Phase 1
- Comparison of Two Combinations in Antiretroviral Post-Exposure Prophylaxis for HIV-1: Tenofovir/Emtricitabine (Truvada ®) + Lopinavir/Ritonavir (Kaletra ®) vs Tenofovir/Emtricitabine/Cobicistat/Elvitegravir (Stribild ®). Prospective, Randomized, Open.CompletedNCT02198443Phase 4
- Bioavailability of 2 Different Nevirapine Extended Release Formulations Compared to Viramune® in HIV-1 Infected SubjectsCompletedNCT02194179Phase 1
- Relative Bioavailability of Different Oral Viramune Extended Release Formulations Compared to Viramune® Oral Suspension in Healthy Male VolunteersCompletedNCT02192463Phase 1
- Tenofovir to Prevent HBV ReactivationStatus unknownNCT02186574Phase 3
- Pharmacokinetic Interaction Between Nevirapine and Saquinavir-sgc in HIV-1 Infected PatientsTerminatedNCT02184286Phase 1
- Study to Evaluate the Effects of Underlying Renal or Hepatic Dysfunction on the Pharmacokinetics of NevirapineCompletedNCT02184091Phase 1
- Study to Determine the Effects of Nevirapine (VIRAMUNE®) on the Steady State Pharmacokinetics of Rifabutin (MYCOBUTIN®) in HIV+ PatientsCompletedNCT02184078Phase 4
- Investigation of the Potential Pharmacokinetic Interaction Between Nevirapine (VIRAMUNE) and Ethinyl Estradiol/Norethindrone in HIV-1 Infected WomenCompletedNCT02182791Phase 1
- Investigation of the Potential Pharmacokinetic Interaction Between Nevirapine, Abacavir and Amprenavir in HIV-1 Infected Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) Naive AdultsTerminatedNCT02182765Phase 1
- Effects of Nevirapine on the Steady State Pharmacokinetics of Fluconazole in HIV Positive PatientsCompletedNCT02181946Phase 4
- Efficacy of Nevirapine Compared to ZDV + 3TC Administered in Labor and Again at Postdelivery in HIV Positive WomenCompletedNCT02181933Phase 3
- Evaluation of Safety, Tolerability, Pharmacokinetics, and Antiretroviral Activity of Ulonivirine (MK-8507) in Human Immunodeficiency Virus (HIV-1)-Infected Participants (MK-8507-003)CompletedNCT02174159Phase 1